You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
吉貝爾(688566.SH)擬投資建設“在研抗腫瘤新藥(JJH201601)原料及製劑車間項目”
格隆匯 01-22 17:12

格隆匯1月22日丨吉貝爾(688566.SH)公佈,為加快推進擬開發為一類新藥的抗腫瘤藥(JJH201601)的項目進程,公司擬自籌資金,投資建設“在研抗腫瘤新藥(JJH201601)原料及製劑車間項目”,用於在研抗腫瘤新藥(JJH201601)的臨牀研究用藥及後續產品的生產。投資金額不超過人民幣1.5億元。項目投資建設主體為公司,預計建設期為15個月,項目建設地點位於鎮江新區新能源產業園內。

公司於2021年1月22日召開公司第三屆董事會第四次會議,審議通過了《關於投資建設在研抗腫瘤新藥(JJH201601)原料及製劑車間項目的議案》,該項目的建成有利於在研抗腫瘤新藥(JJH201601)臨牀研究工作的正常開展。同時,如在研抗腫瘤新藥(JJH201601)能夠研發成功並上市,該項目將用於後續產品的生產。項目的建設符合國家相關法律法規要求,符合公司未來發展戰略及產業佈局方向。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account